DOPTELET

avatrombopag · AkaRx, Inc.

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for DOPTELET, covering 2018-05-21 to 2026-04-08. Get the full timeline:

Most recent: EMA Authorised: Doptelet (avatrombopag maleate) — Swedish Orphan Biovitrum AB (publ)